Pleurotus nebrodensis polysaccharide (PN-S) enhances the immunity of immunosuppressed mice

Chin J Nat Med. 2015 Oct;13(10):760-6. doi: 10.1016/S1875-5364(15)30076-5.

Abstract

In the present study, the effects of Pleurotus nebrodensis polysaccharide (PN-S) on the immune functions of immunosuppressed mice were determined. The immunosuppressed mouse model was established by treating the mice with cyclophosphamide (40 mg/kg/2d, CY) through intraperitoneal injection. The results showed that PN-S administration significantly reversed the CY-induced weight loss, increased the thymic and splenic indices, and promoted proliferation of T lymphocyte, B lymphocyte, and macrophages. PN-S also enhanced the activity of natural killer cells and increased the immunoglobulin M (IgM) and immunoglobulin G (IgG) levels in the serum. In addition, PN-S treatment significantly increased the phagocytic activity of mouse peritoneal macrophages. PN-S also increased the levels of interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), interferon-γ (INF-γ), and nitric oxide (NOS) in splenocytes. qRT-PCR results also indicated that PN-S increased the mRNA expression of IL-6, TNF-α, INF-γ, and nitric oxide synthase (iNOS) in the splenocytes. These results suggest that PN-S treatment enhances the immune function of immunosuppressed mice. This study may provide a basis for the application of this fungus in adjacent immunopotentiating therapy against cancer and in the treatment of chemotherapy-induced immunosuppression.

Keywords: Cyclophosphamide; Immunosuppressed mice; Pleurotus nebrodensis polysaccharide.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents, Alkylating
  • Biological Products / pharmacology*
  • Biological Products / therapeutic use
  • Cell Line
  • Cyclophosphamide
  • Immunity / drug effects*
  • Immunologic Factors / pharmacology*
  • Immunologic Factors / therapeutic use
  • Immunosuppression Therapy*
  • Interferon-gamma / metabolism
  • Interleukin-6 / metabolism
  • Macrophages / drug effects*
  • Macrophages / metabolism
  • Male
  • Mice, Inbred BALB C
  • Neoplasms / drug therapy
  • Neoplasms / immunology
  • Nitric Oxide / metabolism
  • Nitric Oxide Synthase Type II / metabolism
  • Phagocytosis / drug effects
  • Pleurotus / chemistry*
  • Polysaccharides / pharmacology*
  • Polysaccharides / therapeutic use
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Antineoplastic Agents, Alkylating
  • Biological Products
  • IL6 protein, human
  • Immunologic Factors
  • Interleukin-6
  • Polysaccharides
  • Tumor Necrosis Factor-alpha
  • Nitric Oxide
  • Interferon-gamma
  • Cyclophosphamide
  • Nitric Oxide Synthase Type II